Abiopharma

🔍 Quaggin Susan E (Executive)

Company: AbbVie Inc. (ABBV)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 1,118 shares of Common Stock, $0.01 par value (Direct)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,643.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).